At Wake Forest School of Medicine, the Section of Endocrinology and Metabolism’s research efforts concentrate on clinical investigations, primarily addressing diabetes mellitus, a disease affecting more than seventeen million Americans. Patients with type two diabetes mellitus die of cardiovascular disease (CVD) at rates two to four times higher than non-diabetic populations of similar demographic characteristics.
The Section is heavily involved in the multi-center National Institutes of Health (NIH) investigation, Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, an eight-year study involving more than 10,000 participants. The purpose of this research is to identify ways to prevent heart attack, stroke or cardiovascular death in adults with type 2 diabetes mellitus using intensive glycemic control, blood pressure control and lipid management. The trial is testing three complementary medical treatment strategies to enhance the options for reducing morbidity and mortality.
Manuscript Supplementary Data
Swapan Kumar Das, MSc, PhD
Analysis of osteocalcin as a candidate gene for type 2 diabetes (T2D) and intermediated traits in Caucasians and African Americans.